Sunday, June 4Welcome

Thought leadership connects insight and influence

NORTHAMPTON, MA / ACCESSWIRE / October 13, 2022 / In addition to serving about half of the hospitals and doctors in the United States each year, and about one in three adults, quest diagnosis is a recognized thought leader and innovator in COVID-19 research and services. Our original research and key insights highlight the many unforeseen impacts of the pandemic on public health.

Additionally, through Q4HE, we have taken a bold stance to commit to addressing short-term test access inequalities and future disparities in outcomes.

Under its Quest Advanced® products, which were initially focused on neurology, oncology, and women’s and reproductive health, Quest has a deep understanding of healthcare market trends and the development of new high-quality products to meet the emerging clinical needs of patients. We focus on developing tests and solutions. Provider of advanced precision medicine.

It also plays an important role in the field of healthcare.

  • Peer-reviewed research articles in leading medical journals
  • Access to on-demand webinars and national conference presentations through our clinical education center
  • Podcasts on multiple topics from clinical and operational experts
  • Lectures by Quest executives, doctors and researchers
  • Participation in national healthcare leadership groups such as the College of Healthcare Information Management Executives (CHIME) and the American Clinical Laboratory Association (ACLA)

read more

Quest Diagnostics, Thursday, October 13, 2022, press release image

See additional multimedia and other ESG storytelling from Quest Diagnostics on

Contact Information:
Spokesperson: Quest Diagnostics

sauce: quest diagnosis

View source version on

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *